Pharmacological Characterization of FE 202158, a Novel, Potent, Selective, and Short-Acting Peptidic Vasopressin V1aReceptor Full Agonist for the Treatment of Vasodilatory Hypotension-Reference-Cited by-同舟云学术

Pharmacological Characterization of FE 202158, a Novel, Potent, Selective, and Short-Acting Peptidic Vasopressin V1aReceptor Full Agonist for the Treatment of Vasodilatory Hypotension

Published:2011-03-16 Issue:3 Volume:337 Page:786-796
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Laporte Régent,Kohan Arash,Heitzmann Joshua,Wiśniewska Halina,Toy Jeannine,La Erin,Tariga Hiroe,Alagarsamy Sudarkodi,Ly Brian,Dykert John,Qi Steve,Wiśniewski Kazimierz,Galyean Robert,Croston Glenn,Schteingart Claudio D.,Rivière Pierre J.-M.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference38 articles.

1. Pharmacological characterization of F-180: a selective human V1avasopressin receptor agonist of high affinity

2. Septic shock

3. Aurell CJ Bengtsson B Ekholm K Kasprzykowska R Nilsson A Persson R Trojnar J Abbe M Melin P (1991) Development of vasopressor specific vasotocin analogues with prolonged effects, in Peptides 1990, Proceedings of the 21st European Peptide Symposium ( Giralt E Andreu D eds) pp 671–673, Springer, Barcelona, Spain.

4. Structural bases of vasopressin/oxytocin receptor function

5. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxytocin and vasopressin signaling in health and disease;Trends in Biochemical Sciences;2024-04

2. Modified synthetic peptides: from therapeutics to chemosensors;Sensors & Diagnostics;2024

3. Target-Based Screening for Lead Discovery;Interdisciplinary Biotechnological Advances;2023

4. Alternatives to norepinephrine in septic shock: Which agents and when?;Journal of Intensive Medicine;2022-10

5. Vasopressors and Risk of Acute Mesenteric Ischemia: A Worldwide Pharmacovigilance Analysis and Comprehensive Literature Review;Frontiers in Medicine;2022-05-23